Upgrade to SI Premium - Free Trial

Oncolytics Biotech (ONCY) Tops Q1 Loss Views by 3c

May 12, 2011 7:03 AM
Oncolytics Biotech (NASDAQ: ONCY) reported Q1 loss of ($0.06), $0.03 better than the analyst estimate of ($0.09).

Categories

Earnings